Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now
- PMID: 35926930
- PMCID: PMC9352560
- DOI: 10.1016/j.jacc.2022.05.035
Worsening Cardiovascular Disease Epidemiology in the United States: The Time for Preparation Is Now
Keywords: cardiovascular disease; epidemiology; forecasting; prevention; trends.
Conflict of interest statement
Funding Support and Author Disclosures Dr Kalogeropoulos has received research funding from the National Heart, Lung, and Blood Institute, the American Heart Association, and the Centers for Disease Control and Prevention. Dr Butler has been a consultant for Abbott, Amgen, American Regent, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceutical, Impulse Dynamics, Innolife, Janssen, LivaNova, Medtronic, Merck, Novartis, Novo Nordisk, Pfizer, Roche, and Vifor.
Figures




Comment on
-
Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. doi: 10.1016/j.jacc.2022.05.033. J Am Coll Cardiol. 2022. PMID: 35926929 Free PMC article.
References
-
- U.S. Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) Impact of the COVID-19 pandemic on the hospital and outpatient clinician workforce. 2022. https://aspe.hhs.gov/reports/covid-19-health-care-workforce?msclkid=8212...
-
- Association of American Medical Colleges The complexities of physician supply and demand: projections from 2018 to 2033. 2022. https://www.aamc.org/system/files/2020-06/stratcomm-aamc-physician-workf...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources